2023年6月15日

06/15/2023 | 02:02pm美國信息:*必填字段紐約,6月15日,2023年6月15日,從靜脈Group Inc .)(“靜脈”)(NYSE:靜脈),所需要的顛覆性地中海快速偶然餐廳品牌帶來的心,健康,和人類食物,開始在紐約證券交易所交易,其首次公開發行(ipo)定價14444444股每股22.00美元。Invus集團有限責任公司(“Invus”),通過其附屬Artal國際S.C.A. (“Artal”),是驕傲的是一個夥伴以來靜脈靜脈2015係列的一輪投資。Artal仍然公開發行後靜脈的最大股東。Invus董事總經理菲利普Amouyal和便雅憫覺得擔任靜脈的董事會。“我們衷心祝賀靜脈的創始人泰德Xenohristos,艾克Grigoropoulos,迪米特裏Moshovitis,舒爾曼和布雷特和整個靜脈團隊在這個重要的裏程碑和開始一個新的公司的章,“說的感受。“我們一直深感榮幸與靜脈合作從少數餐館現在全美數百,我們期待看到靜脈繼續傳播地中海在未來幾年。”This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About Invus and Artal Invus, as exclusive investment advisor to Artal, is a global equity investment firm with an evergreen capital structure, operating out of offices in the U.S., Europe and Asia. Since its founding in 1985, Invus has focused on empowering entrepreneurs and entrepreneurial teams to transform their industries across both public and private equity investments. View original content to download multimedia: https://www.prnewswire.com/news-releases/the-invus-group-congratulates-cava-on-nyse-ipo-301852373.html SOURCE The Invus Group, LLC © PRNewswire 2023